Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Injectables: SOP for Endotoxin Testing

Posted on By

SOP for Endotoxin Testing

Standard Operating Procedure for Endotoxin Testing

1) Purpose

The purpose of this SOP is to outline the procedures for performing endotoxin testing on pharmaceutical products to ensure they are free from pyrogenic contamination.

2) Scope

This SOP applies to all pharmaceutical products that require endotoxin testing within the facility, including raw materials, in-process samples, and finished products.

3) Responsibilities

3.1 Microbiologist
– Perform endotoxin tests as per this SOP.
– Document and report test results accurately.
3.2 Laboratory Supervisor
– Ensure all testing procedures are followed.
– Review and approve endotoxin test records.
3.3 Quality Assurance (QA) Personnel
– Validate endotoxin testing methods.
– Ensure compliance with regulatory guidelines.

See also  SOP for Syringe Filling and Capping (for SC injections)

4) Procedure

4.1 Preparation
4.1.1 Clean and disinfect the testing area and equipment.
4.1.2 Prepare reagents and standards as specified in the test method.
4.2 Sampling
4.2.1 Collect samples aseptically to prevent contamination.
4.2.2 Transport samples to the testing area in sterile containers.
4.3 Testing Methods
4.3.1 Use the Limulus Amebocyte Lysate (LAL) test method for endotoxin detection.
4.3.2 Prepare test samples, positive controls, and negative controls according to the LAL test kit instructions.
4.3.3 Incubate test samples and controls at specified conditions (e.g., temperature, time).
4.4 Monitoring and Documentation
4.4.1 Monitor samples for endotoxin levels

during the incubation period.
4.4.2 Record observations and test results in the Endotoxin Test Log.
4.5 Reporting
4.5.1 Compile test results and prepare an endotoxin test report.
4.5.2 Submit the report to QA for review and approval.
4.6 Investigation of Failures
4.6.1 Investigate any positive endotoxin test results to determine the source of contamination.
4.6.2 Implement corrective actions to prevent recurrence.

See also  Injectables: SOP for Handling Deviations during Manufacturing

5) Abbreviations, if any

– LAL: Limulus Amebocyte Lysate
– QA: Quality Assurance

6) Documents, if any

– Endotoxin Test Log
– Endotoxin Test Reports
– Reagent Preparation Records

7) Reference, if any

– United States Pharmacopeia (USP) <85> Bacterial Endotoxins Test
– European Pharmacopoeia (Ph. Eur.) 2.6.14 Bacterial Endotoxins

8) SOP Version

Version 1.0

Injectables Tags:Analytical method validation for injections, Aseptic media fill trials SOP, Bioburden testing for injections, Cleaning validation for injection equipment, Emulsion stability testing for injections, Formulation development for injections, Homogeneity testing for injections, IM injection SOP, Injection filling volume accuracy, Injection stability testing, Intramuscular injection procedure, Intravenous injection guidelines, IV injection SOP, Needle assembly for syringes SOP, Packaging integrity testing for injections, Particle size analysis for injections, Pre-filled syringe stability testing, Product sterility in aseptic processing, Reconstitution testing for injections, SC injection SOP, Subcutaneous injection technique, Syringe filling and capping SOP, Syringe labeling and inspection SOP, Temperature mapping in storage areas, Viscosity testing for injections

Post navigation

Previous Post: In-Process Control: SOP for Homogeneity Testing in Transdermal Patches
Next Post: SOP for Supplier Performance Evaluation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version